{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:03:34Z","timestamp":1791338614385,"version":"4.3.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.056","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T11:25:34Z","timestamp":1573730734000},"page":"570-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion\/empyema after the introduction of PCV13 in Germany"],"prefix":"10.1016","volume":"38","author":[{"given":"D.","family":"Goettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Streng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kemmling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"von Kries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-4914","authenticated-orcid":false,"given":"J.G.","family":"Liese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0005","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J Glob Health"},{"issue":"9966","key":"10.1016\/j.vaccine.2019.10.056_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000\u201313, with projections to inform post-2015 priorities: an updated systematic analysis","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.056_b0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"Grijalva CG: U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2004-822699","article-title":"Population-based incidence of severe pneumonia in children in Kiel, Germany","volume":"217","author":"Weigl","year":"2005","journal-title":"Klin Padiatr"},{"issue":"11","key":"10.1016\/j.vaccine.2019.10.056_b0025","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/522996","article-title":"Diagnosis and management of parapneumonic effusions and empyema","volume":"45","author":"Sahn","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.056_b0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-8-90","article-title":"Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease","volume":"8","author":"Nyambat","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.056_b0035","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study","author":"Liese","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.2009-0184","article-title":"Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine","volume":"125","author":"Li","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.10.056_b0045","unstructured":"STIKO: Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2001. Epidemiol Bull 2001, 28: 201\u201318. https:\/\/doi.org\/https:\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/epid_bull_node.html."},{"issue":"10","key":"10.1016\/j.vaccine.2019.10.056_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.10.056_b0055","unstructured":"STIKO: Neuerungen in den aktuellen Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am RKI vom Juli 2006. Epidemiol Bull 2006, 32: 271\u201380. https:\/\/doi.org\/https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/epid_bull_node.html."},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.056_b0060","first-page":"309","article-title":"Determination of vaccination quotas for pneumococcal conjugate vaccine in children on the basis of routine data of the statutory health insurance","volume":"75","author":"Theidel","year":"2013","journal-title":"Gesundheitswesen"},{"issue":"10","key":"10.1016\/j.vaccine.2019.10.056_b0065","doi-asserted-by":"crossref","first-page":"21057","DOI":"10.2807\/1560-7917.ES2015.20.10.21057","article-title":"Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012","volume":"20","author":"Weiss","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.10.056_b0070","unstructured":"STIKO: Wissenschaftliche Begr\u00fcndung zur \u00c4nderung der Pneumokokken-Impfempfehlung f\u00fcr S\u00e4uglinge. Epidemiol Bull 2015, 36: 377\u201392. https:\/\/doi.org\/10.17886\/EpiBull-2015-005."},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.056_b0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.056_b0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-014-2062-6","article-title":"Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology","volume":"33","author":"Fletcher","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MCP.0b013e3283606ab5","article-title":"The increasing incidence of empyema","volume":"19","author":"Burgos","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.056_b0090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/JCM.01827-10","article-title":"Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients","volume":"49","author":"Yu","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.056_b0095","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3201\/eid2407.180029","article-title":"Pediatric complicated pneumonia caused by streptococcus pneumoniae serotype 3 in 13-valent pneumococcal conjugate vaccinees, portugal, 2010\u20132015","volume":"24","author":"Silva-Costa","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.056_b0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2014-306525","article-title":"Has the incidence of empyema in Scottish children continued to increase beyond 2005?","volume":"100","author":"Nath","year":"2015","journal-title":"Arch Dis Child"},{"issue":"50","key":"10.1016\/j.vaccine.2019.10.056_b0105","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.vaccine.2016.10.062","article-title":"Grijalva CG: Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era","volume":"34","author":"Wiese","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0110","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/INF.0000000000001798","article-title":"Pneumococcal vaccination and pneumonia associated with pleural effusion in a pediatric population","volume":"37","author":"Bernaola","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.056_b0115","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.056_b0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/00365540802688378","article-title":"Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine","volume":"41","author":"Goldbart","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0125","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/JCM.01454-08","article-title":"Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007","volume":"47","author":"Fenoll","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0130","first-page":"215","article-title":"25 Years of ESPED as a surveillance tool for rare diseases in children in Germany: a critical analysis","volume":"230","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Klin Padiatr"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates","volume":"44","author":"Pai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.10.056_b0140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1099\/jmm.0.47347-0","article-title":"Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children","volume":"56","author":"Dias","year":"2007","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 Causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/INF.0000000000001041","article-title":"Vaccine failures in patients properly vaccinated with 13-valent pneumococcal conjugate vaccine in catalonia, a region with low vaccination coverage","volume":"35","author":"Moraga-Llop","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.056_b0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurpub\/ckw089","article-title":"Pneumococcal pneumonia vaccine breakthroughs and failures after 13-valent pneumococcal conjugated vaccine","volume":"26","author":"Almeida","year":"2016","journal-title":"Eur J Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.056_b0160","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.vaccine.2011.12.048","article-title":"The concept of vaccination failure","volume":"30","author":"Heininger","year":"2012","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2019.10.056_b0165","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1016\/j.vaccine.2017.06.057","article-title":"Impact of PCV13 on community-acquired pneumonia by C-reactive protein and procalcitonin levels in children","volume":"35","author":"Levy","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/14760584.2019.1582337","article-title":"Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States","volume":"18","author":"Wiese","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2019.10.056_b0175","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal pneumonia requiring hospitalization in US Children in the 13-valent pneumococcal conjugate vaccine era","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.056_b0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.vaccine.2017.11.054","article-title":"Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec","volume":"36","author":"De Wals","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2019.10.056_b0190","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2019.03.015","article-title":"Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study","volume":"37","author":"Picazo","year":"2019","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2019.10.056_b0195","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/j.vaccine.2019.04.012","article-title":"Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006\u20132018","volume":"37","author":"Azzari","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.056_b0200","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2017.11.085","article-title":"Invasive pneumococcal disease in children under 16years of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany","volume":"36","author":"Weinberger","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"52","key":"10.1016\/j.vaccine.2019.10.056_b0210","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.056_b0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.10.056_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2016.e00198","article-title":"The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination","volume":"2","author":"Slotved","year":"2016","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.056_b0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.056_b0230","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ppul.24279","article-title":"Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era","volume":"54","author":"Diaz-Conradi","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.10.056_b0235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.2010.156406","article-title":"Emergence of parapneumonic empyema in the USA","volume":"66","author":"Grijalva","year":"2011","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.vaccine.2019.10.056_b0240","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/586747","article-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter?","volume":"46","author":"Bender","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2019.10.056_b0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jfma.2013.05.015","article-title":"Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan","volume":"112","author":"Shen","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2019.10.056_b0250","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1139","article-title":"Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines \u2013 a prospective population-based cohort study","author":"Asner","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.056_b0255","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.056_b0260","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/erv.11.76","article-title":"Review on the immunogenicity and safety of PCV-13 in infants and toddlers","volume":"10","author":"Nunes","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2019.10.056_b0265","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/INF.0b013e318233049d","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada","volume":"31","author":"Vanderkooi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2019.10.056_b0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.pone.0161257","article-title":"Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in germany","volume":"11","author":"van der Linden","year":"2016","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2019.10.056_b0280","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciy920","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of observational studies","volume":"68","author":"Sings","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.056_b0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/INF.0000000000000041","article-title":"Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine","volume":"33","author":"Antachopoulos","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.056_b0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00365548.2012.737019","article-title":"Two cases of hemolytic uremic syndrome caused by Streptococcus pneumoniae serotype 3, one being a vaccine failure","volume":"45","author":"Novak","year":"2013","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.056_b0295","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/INF.0000000000000252","article-title":"Serotype 3 pneumococcal pleural empyema in an immunocompetent child after 13-valent pneumococcal conjugate vaccine","volume":"33","author":"Madhi","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2019.10.056_b0300","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/INF.0000000000000818","article-title":"Pneumococcal meningitis vaccine breakthroughs and failures after routine 7-valent and 13-valent pneumococcal conjugate vaccination in children in France","volume":"34","author":"Godot","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.056_b0305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.10.056_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206927","article-title":"Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR)","volume":"13","author":"Abu Seir","year":"2018","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.056_b0315","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.056_b0320","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/CVI.00591-15","article-title":"Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies","volume":"23","author":"Choi","year":"2016","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:48Z","timestamp":1759401468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314367"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.056","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736931954.793573952","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion\/empyema after the introduction of PCV13 in Germany","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}